Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taglidine fumarate dose exploration vs morphine for postoperative pain after laparoscopic hysterectomy
ChiCTR2500109858Phase 4Not yet recruiting
- Sponsor
- Anqing Municipal Hospital
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of tegileridine in postoperative pain (4 arms), sponsored by Anqing Municipal Hospital. Primary endpoint: Resting and movement VAS pain scores over 24 hours. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2500109858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109858.